Eric Devroe

Biography

Eric Devroe is the Chief Executive Officer of Opsonix and has been an entrepreneurial leader and founding team member of multiple life science start-up companies. He has most recently served as Entrepreneur in Residence at the Wyss Institute for Biologically Inspired Engineering at Harvard University, establishing the product development and commercialization strategy for Opsonix and its pathogen extracting therapy. Prior to his work related to Opsonix, Dr. Devroe served as Executive Director of Strategic Alliances at The University of Texas MD Anderson Cancer Center. His recent experience with life sciences start-up companies includes serving as the Vice President of Business & Strategy Development at Metamark Genetics, and an Associate at Flagship Ventures. Earlier in his career, he held scientific and operating roles at Ambion and Codon Devices. Dr. Devroe has authored 12 scientific publications and more than 20 pending and issued patents. He holds a B.S. in Microbiology from the University of Texas at Austin and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University.

Research Interest

Product evelopment and commercialization strategy, Microbiology, Biological Chemistry